Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Operating Margin (2019 - 2025)

Historic Operating Margin for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to 66.94%.

  • Pulmonx's Operating Margin rose 23700.0% to 66.94% in Q3 2025 from the same period last year, while for Sep 2025 it was 62.38%, marking a year-over-year increase of 110200.0%. This contributed to the annual value of 68.87% for FY2024, which is 213200.0% up from last year.
  • As of Q3 2025, Pulmonx's Operating Margin stood at 66.94%, which was up 23700.0% from 62.05% recorded in Q2 2025.
  • In the past 5 years, Pulmonx's Operating Margin ranged from a high of 56.46% in Q4 2024 and a low of 145.28% during Q1 2022
  • In the last 5 years, Pulmonx's Operating Margin had a median value of 85.9% in 2023 and averaged 88.82%.
  • Data for Pulmonx's Operating Margin shows a peak YoY increase of 2098800bps (in 2021) and a maximum YoY decrease of -643300bps (in 2021) over the last 5 years.
  • Pulmonx's Operating Margin (Quarter) stood at 90.21% in 2021, then decreased by -5bps to 94.83% in 2022, then grew by 24bps to 72.2% in 2023, then rose by 22bps to 56.46% in 2024, then fell by -19bps to 66.94% in 2025.
  • Its Operating Margin was 66.94% in Q3 2025, compared to 62.05% in Q2 2025 and 64.62% in Q1 2025.